Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Red ginseng oil and its components help promote hair regrowth and could treat hair loss.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

New compounds may soon be tested to treat excessive hair growth in women.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Treat pattern hair loss with finasteride and topical minoxidil.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Antiandrogen therapy helps treat genetic hair loss.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.